KR100233209B1 - 메타노안트라센 화합물 - Google Patents

메타노안트라센 화합물 Download PDF

Info

Publication number
KR100233209B1
KR100233209B1 KR1019920014635A KR920014635A KR100233209B1 KR 100233209 B1 KR100233209 B1 KR 100233209B1 KR 1019920014635 A KR1019920014635 A KR 1019920014635A KR 920014635 A KR920014635 A KR 920014635A KR 100233209 B1 KR100233209 B1 KR 100233209B1
Authority
KR
South Korea
Prior art keywords
mmol
dihydro
chloro
general formula
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019920014635A
Other languages
English (en)
Korean (ko)
Other versions
KR930004234A (ko
Inventor
톰즈 제이컵스 로버트
존 온마크트 사이러스
에이미 트레이너 다이안
Original Assignee
앤쥼 쉐이크 바쉬어
임페리알 케미칼 인더스트리즈 피엘씨
마틴 험프리스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919117644A external-priority patent/GB9117644D0/en
Priority claimed from GB929207539A external-priority patent/GB9207539D0/en
Application filed by 앤쥼 쉐이크 바쉬어, 임페리알 케미칼 인더스트리즈 피엘씨, 마틴 험프리스 filed Critical 앤쥼 쉐이크 바쉬어
Publication of KR930004234A publication Critical patent/KR930004234A/ko
Application granted granted Critical
Publication of KR100233209B1 publication Critical patent/KR100233209B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1019920014635A 1991-08-15 1992-08-14 메타노안트라센 화합물 Expired - Fee Related KR100233209B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919117644A GB9117644D0 (en) 1991-08-15 1991-08-15 Amine derivatives
GB929207539A GB9207539D0 (en) 1992-04-07 1992-04-07 Therapeutic agents
GB9207539.9 1992-04-07
GB9117644.6 1992-04-07

Publications (2)

Publication Number Publication Date
KR930004234A KR930004234A (ko) 1993-03-22
KR100233209B1 true KR100233209B1 (ko) 1999-12-01

Family

ID=26299413

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920014635A Expired - Fee Related KR100233209B1 (ko) 1991-08-15 1992-08-14 메타노안트라센 화합물

Country Status (20)

Country Link
US (3) US5399568A (enExample)
EP (1) EP0532177B1 (enExample)
JP (1) JP3281047B2 (enExample)
KR (1) KR100233209B1 (enExample)
AT (1) ATE144252T1 (enExample)
AU (1) AU652653B2 (enExample)
CA (1) CA2076168A1 (enExample)
CZ (1) CZ251892A3 (enExample)
DE (1) DE69214586T2 (enExample)
DK (1) DK0532177T3 (enExample)
ES (1) ES2092645T3 (enExample)
FI (1) FI923662A7 (enExample)
GB (1) GB9216297D0 (enExample)
GR (1) GR3021399T3 (enExample)
HU (1) HUT66623A (enExample)
IE (1) IE922587A1 (enExample)
IL (1) IL102806A0 (enExample)
NO (1) NO923198L (enExample)
NZ (1) NZ243954A (enExample)
TW (1) TW222622B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
US5514683A (en) * 1992-02-20 1996-05-07 James Black Foundation Limited Bicyclo 2,2,2!octane derivatives
US5530012A (en) * 1994-12-22 1996-06-25 Bristol-Myers Squibb Co. 3-alkoxybenzylpiperidine derivatives as melatonergic agents
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US20070225217A1 (en) 2005-11-09 2007-09-27 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
CA2685888A1 (en) * 2007-05-09 2008-11-20 Pfizer Inc. Substituted heterocyclic derivatives and their pharmaceutical use and compositions

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455928A (en) * 1960-11-29 1969-07-15 Ciba Geigy Corp 9:10-dihydro-9:10-ethanoanthracen-9-alkanamides
BE610863A (fr) * 1960-11-29 1962-05-28 Ciba Geigy Procédé de préparation de nouvelles amines, entre autres de 9-amino-alcoyl-9,10-dihydro-9,10-éthano-(1,2)-anthracènes
BE674185A (enExample) * 1961-10-10
FR176F (enExample) * 1965-05-19
US3489799A (en) * 1967-09-26 1970-01-13 Ciba Geigy Corp Ethano-anthracenes
CH539602A (de) * 1969-03-25 1973-09-14 Ciba Geigy Ag Verfahren zur Herstellung von neuen N-substituierten 9-(Aminoalkyl)-9,10-dihydro-9,10-äthano-anthrazenen
ES367292A1 (es) * 1968-05-16 1971-05-01 Ciba Geigy Procedimiento para la obtencion de 9-(aminoalquilo)-9,10- dihidro - 9,10-etanoantracenos sustituidos.
US3706765A (en) * 1969-01-03 1972-12-19 Ciba Geigy Corp Hydroxyethano-anthracenes
DE2021668A1 (de) * 1969-05-10 1970-11-19 Ciba Geigy Neue Amine und Verfahren zu ihrer Herstellung
US3870796A (en) * 1970-11-27 1975-03-11 Ciba Geigy Corp Pharmaceutical preparation
US4017542A (en) * 1971-02-23 1977-04-12 Ciba-Geigy Corporation 9-(2-Hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes and salts thereof
US4045580A (en) * 1971-02-23 1977-08-30 Ciba-Geigy Corporation Pharmaceutical preparation using 9-(2-hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes as antidepressants
JPS5911576B2 (ja) * 1975-07-07 1984-03-16 住友化学工業株式会社 新規なメタノ−アントラセン誘導体の製造法
US4224344A (en) * 1974-12-13 1980-09-23 Sumitomo Chemical Company, Limited Organic tricyclic compounds
US4358620A (en) * 1974-12-13 1982-11-09 Sumitomo Chemical Company, Limited 9-Formyl-9,10-dihydro-9,10-methanoanthracene
JPS527972A (en) * 1975-07-07 1977-01-21 Sumitomo Chem Co Ltd Process for preparing novel morpholine derivatives
JPS5268170A (en) * 1975-12-03 1977-06-06 Sumitomo Chem Co Ltd Preparation of novel methano-anthracene derivatives
GB1531278A (en) * 1975-12-15 1978-11-08 Shionogi & Co 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof
JPS5910654B2 (ja) * 1976-04-07 1984-03-10 住友化学工業株式会社 新規なメタノ−アントラセン誘導体
JPS5936621B2 (ja) * 1976-05-19 1984-09-05 大塚製薬株式会社 新規なカルボスチリル誘導体
US4318926A (en) * 1979-08-14 1982-03-09 Ciba-Geigy Corporation Method of curing or alleviating herpes infections and pharmaceutical compositions suitable therefor
US5226570A (en) * 1991-07-16 1993-07-13 Fabio Pedrini Self-centering roof rack
GB9117639D0 (en) * 1991-08-15 1991-10-02 Ici Plc Therapeutic compounds
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
JP3005175U (ja) 1993-08-23 1994-12-13 有限会社サンエイ レンタルショップ用ビデオケース

Also Published As

Publication number Publication date
DE69214586T2 (de) 1997-03-20
US5719166A (en) 1998-02-17
KR930004234A (ko) 1993-03-22
NZ243954A (en) 1995-09-26
EP0532177A1 (en) 1993-03-17
DK0532177T3 (da) 1997-03-24
IE922587A1 (en) 1993-02-24
DE69214586D1 (de) 1996-11-21
CZ251892A3 (en) 1993-02-17
HUT66623A (en) 1994-12-28
GB9216297D0 (en) 1992-09-16
NO923198L (no) 1993-02-16
JPH05246988A (ja) 1993-09-24
IL102806A0 (en) 1993-01-31
AU2101792A (en) 1993-02-18
CA2076168A1 (en) 1993-02-16
FI923662L (fi) 1993-02-16
US5550136A (en) 1996-08-27
FI923662A0 (fi) 1992-08-14
AU652653B2 (en) 1994-09-01
US5399568A (en) 1995-03-21
JP3281047B2 (ja) 2002-05-13
NO923198D0 (no) 1992-08-14
FI923662A7 (fi) 1993-02-16
EP0532177B1 (en) 1996-10-16
ES2092645T3 (es) 1996-12-01
GR3021399T3 (en) 1997-01-31
ATE144252T1 (de) 1996-11-15
HU9202641D0 (en) 1992-10-28
TW222622B (enExample) 1994-04-21

Similar Documents

Publication Publication Date Title
US6303633B1 (en) Heteroaryl amines as novel acetylcholinesterase inhibitors
KR100818875B1 (ko) 리스페리돈의 제조
JP3538431B2 (ja) 腫瘍細胞増殖予防薬を調製するためのアミンの使用
KR100245955B1 (ko) 메타노안트라센화합물
JPWO2007058304A1 (ja) シンナミド化合物の塩またはそれらの溶媒和物
US5670522A (en) Dopamine receptor subtype ligands
JP3269574B2 (ja) メタノアントラセン化合物、これを含有する神経精神障害を治療するための調剤学的組成物、およびこの化合物を製造するための方法および中間体
JPWO1998000400A1 (ja) テトラヒドロベンズインドール化合物
KR100233209B1 (ko) 메타노안트라센 화합물
JPWO2009041559A1 (ja) インダゾールアクリル酸アミド化合物
US5512575A (en) Methanoanthraceneyl methyl piperidinyl compounds
EP3741744B1 (en) A pharmaceutical intermediate for preparing pimavanserin
US5821245A (en) Use of naphthalene derivatives in treating lung carcinoma
US6306853B1 (en) 1,4-Dihydropyridine derivatives
RU2128178C1 (ru) Пиперидинилзамещенные метаноантрацены и их фармацевтически приемлемые соли, фармацевтическая композиция на их основе и способы их получения
CA2107665A1 (en) 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
JPS62267269A (ja) ピラゾ−ル−３−アミン類
JP2010229096A (ja) 医薬組成物

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20020911

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20020911

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000